Araceli Biosciences raises $11.2M for imaging and AI analysis systems to help speed drug discovery

Araceli Biosciences raises $11.2M for imaging and AI analysis systems to help speed drug discovery

Araceli Biosciences raises $11.2M for imaging and AI analysis systems to help speed drug discoveryAraceli Biosciences raises $11.2M for imaging and AI analysis systems to help speed drug discovery

Portland-based biotech company Araceli Biosciences raised $11.2 million in new funding to fuel the expansion of its high-content imaging technology and AI-powered analysis used to speed drug discovery. Araceli’s flagship platform is the Endeavor high content imaging system, which is designed for ultra high-throughput imaging — a process that measures the effects of chemical or genetic changes on cellular phenotypes. The imaging is used to gather data that provides a more thorough understanding of cellular responses to potential drug candidates. According to Araceli, traditional imaging systems lack speed and scalability, and Endeavor delivers results up to 40 times faster across... Read More

Share
Related News